Literature DB >> 24756139

Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.

Maria Luisa Belli1, Elisa Scalco, Giuseppe Sanguineti, Claudio Fiorino, Sara Broggi, Nicola Dinapoli, Francesco Ricchetti, Vincenzo Valentini, Giovanna Rizzo, Giovanni Mauro Cattaneo.   

Abstract

PURPOSE: To quantitatively assess the predictive power of early variations of parotid gland volume and density on final changes at the end of therapy and, possibly, on acute xerostomia during IMRT for head-neck cancer.
MATERIALS AND METHODS: Data of 92 parotids (46 patients) were available. Kinetics of the changes during treatment were described by the daily rate of density (rΔρ) and volume (rΔvol) variation based on weekly diagnostic kVCT images. Correlation between early and final changes was investigated as well as the correlation with prospective toxicity data (CTCAEv3.0) collected weekly during treatment for 24/46 patients.
RESULTS: A higher rΔρ was observed during the first compared to last week of treatment (-0,50 vs -0,05HU, p-value = 0.0001). Based on early variations, a good estimation of the final changes may be obtained (Δρ: AUC = 0.82, p = 0.0001; Δvol: AUC = 0.77, p = 0.0001). Both early rΔρ and rΔvol predict a higher "mean" acute xerostomia score (≥ median value, 1.57; p-value = 0.01). Median early density rate changes for patients with mean xerostomia score ≥ / < 1.57 were -0.98 vs -0.22 HU/day respectively (p = 0.05).
CONCLUSIONS: Early density and volume variations accurately predict final changes of parotid glands. A higher longitudinally assessed score of acute xerostomia is well predicted by higher rΔρ and rΔvol in the first two weeks of treatment: best cut-off values were -0.50 HU/day and -380 mm(3)/day for rΔρ and rΔvol respectively. Further studies are necessary to definitively assess the potential of early density/volume changes in identifying more sensitive patients at higher risk of experiencing xerostomia.

Entities:  

Mesh:

Year:  2014        PMID: 24756139     DOI: 10.1007/s00066-014-0669-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  21 in total

1.  A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer.

Authors:  Sara Broggi; Claudio Fiorino; Italo Dell'Oca; Nicola Dinapoli; Marta Paiusco; Alessandro Muraglia; Eleonora Maggiulli; Francesco Ricchetti; Vincenzo Valentini; Giuseppe Sanguineti; Giovanni Mauro Cattaneo; Nadia Di Muzio; Riccardo Calandrino
Journal:  Radiother Oncol       Date:  2010-02-01       Impact factor: 6.280

2.  Investigations on parotid gland recovery after IMRT in head and neck tumor patients.

Authors:  Markus Stock; Wolfgang Dörr; Carmen Stromberger; Ulrike Mock; Susanne Koizar; Richard Pötter; Dietmar Georg
Journal:  Strahlenther Onkol       Date:  2010-11-30       Impact factor: 3.621

Review 3.  Salivary glands.

Authors:  A R Silvers; P M Som
Journal:  Radiol Clin North Am       Date:  1998-09       Impact factor: 2.303

4.  Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.

Authors:  Claudio Fiorino; Giovanna Rizzo; Elisa Scalco; Sara Broggi; Maria Luisa Belli; Italo Dell'Oca; Nicola Dinapoli; Francesco Ricchetti; Aldo Mejia Rodriguez; Nadia Di Muzio; Riccardo Calandrino; Giuseppe Sanguineti; Vincenzo Valentini; Giovanni Mauro Cattaneo
Journal:  Radiother Oncol       Date:  2012-07-16       Impact factor: 6.280

5.  An automatic contour propagation method to follow parotid gland deformation during head-and-neck cancer tomotherapy.

Authors:  E Faggiano; C Fiorino; E Scalco; S Broggi; M Cattaneo; E Maggiulli; I Dell'Oca; N Di Muzio; R Calandrino; G Rizzo
Journal:  Phys Med Biol       Date:  2011-01-14       Impact factor: 3.609

6.  Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancer.

Authors:  Keiko Teshima; Ryuji Murakami; Ryoji Yoshida; Hideki Nakayama; Akimitsu Hiraki; Toshinori Hirai; Yuji Nakaguchi; Naoko Tsujita; Etsushi Tomitaka; Mitsuhiro Furusawa; Yasuyuki Yamashita; Masanori Shinohara
Journal:  J Radiat Res       Date:  2012-04-09       Impact factor: 2.724

7.  Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Authors:  K H Bohuslavizki; S Klutmann; C Bleckmann; W Brenner; S Lassmann; J Mester; E Henze; M Clausen
Journal:  Strahlenther Onkol       Date:  1999-02       Impact factor: 3.621

8.  Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study.

Authors:  Claudio Fiorino; Italo Dell'Oca; Alessio Pierelli; Sara Broggi; Giovanni Mauro Cattaneo; Anna Chiara; Elena De Martin; Nadia Di Muzio; Ferruccio Fazio; Riccardo Calandrino
Journal:  Strahlenther Onkol       Date:  2007-09       Impact factor: 3.621

9.  Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration.

Authors:  Eliana M Vásquez Osorio; Mischa S Hoogeman; Abrahim Al-Mamgani; David N Teguh; Peter C Levendag; Ben J M Heijmen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-01       Impact factor: 7.038

10.  Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer.

Authors:  A Fiorentino; R Caivano; V Metallo; C Chiumento; M Cozzolino; G Califano; S Clemente; P Pedicini; V Fusco
Journal:  Br J Radiol       Date:  2012-05-09       Impact factor: 3.039

View more
  11 in total

1.  Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.

Authors:  Benjamin S Rosen; Peter G Hawkins; Daniel F Polan; James M Balter; Kristy K Brock; Justin D Kamp; Christina M Lockhart; Avraham Eisbruch; Michelle L Mierzwa; Randall K Ten Haken; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-10       Impact factor: 7.038

2.  Parotid gland shrinkage during IMRT predicts the time to Xerostomia resolution.

Authors:  Giuseppe Sanguineti; Francesco Ricchetti; Binbin Wu; Todd McNutt; Claudio Fiorino
Journal:  Radiat Oncol       Date:  2015-01-17       Impact factor: 3.481

3.  A Nomogram to predict parotid gland overdose in head and neck IMRT.

Authors:  J Castelli; A Simon; B Rigaud; C Lafond; E Chajon; J D Ospina; P Haigron; B Laguerre; A Ruffier Loubière; K Benezery; R de Crevoisier
Journal:  Radiat Oncol       Date:  2016-06-08       Impact factor: 3.481

4.  Structural Variations in Parotid Glands Induced by Radiation Therapy in Patients with Oral Carcinoma Observed on Contrast-Enhanced Computed Tomography.

Authors:  Ichiro Ogura; Yoshihiko Sasaki; Takaaki Oda; Mikiko Sue; Haruka Yamaguchi; Ayako Kameta; Kazuhide Hayama; Makoto Tsuchimochi
Journal:  Pol J Radiol       Date:  2017-09-15

5.  Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.

Authors:  Jingjiao Lou; Pu Huang; Changsheng Ma; Yue Zheng; Jinhu Chen; Yueqiang Liang; Hongsheng Li; Yong Yin; Danhua Liu; Gang Yu; Dengwang Li
Journal:  J Appl Clin Med Phys       Date:  2018-04-17       Impact factor: 2.102

6.  Investigation of a Novel Decision Support Metric for Head and Neck Adaptive Radiation Therapy Using a Real-Time In Vivo Portal Dosimetry System.

Authors:  S B Lim; C J Tsai; Y Yu; P Greer; T Fuangrod; K Hwang; S Fontenla; F Coffman; N Lee; D M Lovelock
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

7.  Delta-radiomics features during radiotherapy improve the prediction of late xerostomia.

Authors:  Lisanne V van Dijk; Johannes A Langendijk; Tian-Tian Zhai; Thea A Vedelaar; Walter Noordzij; Roel J H M Steenbakkers; Nanna M Sijtsema
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

8.  Radiation-induced parotid changes in oropharyngeal cancer patients: the role of early functional imaging and patient-/treatment-related factors.

Authors:  Simona Marzi; Alessia Farneti; Antonello Vidiri; Francesca Di Giuliano; Laura Marucci; Filomena Spasiano; Irene Terrenato; Giuseppe Sanguineti
Journal:  Radiat Oncol       Date:  2018-10-01       Impact factor: 3.481

Review 9.  Radiomics for radiation oncologists: are we ready to go?

Authors:  Loïg Vaugier; Ludovic Ferrer; Laurence Mengue; Emmanuel Jouglar
Journal:  BJR Open       Date:  2020-03-25

10.  Can the Risk of Dysphagia in Head and Neck Radiation Therapy Be Predicted by an Automated Transit Fluence Monitoring Process During Treatment? A First Comparative Study of Patient Reported Quality of Life and the Fluence-Based Decision Support Metric.

Authors:  Seng Boh Lim; Nancy Lee; Kaveh Zakeri; Peter Greer; Todsaporn Fuangrod; Frederick Coffman; Laura Cerviño; D Michael Lovelock
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.